TELA Bio, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by TELA Bio, Inc. (TELA) on September 15, 2026. The report addresses a critical corporate governance and listing status event concerning the company's common stock on the Nasdaq Global Market.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The report focuses exclusively on regulatory compliance regarding stock listing standards rather than operational financial performance.
Material Changes and Events
- Delisting Notice: On September 15, 2026, Nasdaq notified the Company that its common stock is subject to delisting due to failure to regain compliance with the Minimum Bid Price Requirement (Rule 5450(a)(1)).
- Non-Compliance History: The stock price remained below $1.00 per share for 30 consecutive business days starting March 17, 2026, and the Company failed to regain compliance within the 180-calendar day grace period ending September 14, 2026.
- Reverse Stock Split Proposal: On September 14, 2026, the Company filed a proxy statement seeking stockholder approval for a reverse stock split with a ratio ranging from 1-for-5 to 1-for-15.
- Special Meeting: A special meeting to vote on the reverse stock split is scheduled for October 8, 2026.
Outlook, Management Commentary, and Risks
- Hearing Request: The Company intends to request a hearing before a Nasdaq Hearings Panel. This request will automatically stay any suspension or delisting pending the conclusion of the process.
- Compliance Path: To regain compliance, the closing bid price must be at least $1.00 per share for 10 to 20 consecutive business days.
- Uncertainty: Management explicitly states it cannot assure that the reverse stock split proposal will be approved by stockholders at the special meeting.
- Forward-Looking Statements: The filing includes standard disclaimers regarding risks related to the trading price of common stock and the ability to maintain listing status.
Investor Verification Checklist
- Verify the outcome of the special stockholder meeting scheduled for October 8, 2026, regarding the reverse stock split.
- Monitor the Nasdaq Hearings Panel decision and the status of the delisting stay.
- Track the daily closing bid price of TELA stock to assess progress toward the $1.00 minimum requirement.
- Review the Company's most recent Form 10-K and 10-Q for detailed financial risks and liquidity positions not included in this 8-K.